Other OTC - Delayed Quote • USD
DIAGNOS Inc. (DGNOF)
As of 10:17 AM EDT. Market Open.
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Andre Larente | CEO, President & Executive Chairman | 214k | -- | -- |
| Mr. Marc-André Massue | VP of Finance, CFO & Secretary | 103.79k | -- | -- |
| Mr. Yves-Stéphane Couture | Chief Operating Officer | -- | -- | -- |
| Mr. Martin Beland | Director of Marketing | -- | -- | -- |
DIAGNOS Inc.
- Sector:
- Healthcare
- Industry: Health Information Services
Description
DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.
Corporate Governance
DIAGNOS Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
- Apr 24, 2019Dividend Date
Upcoming Events
Jul 11, 2024 - Jul 15, 2024
DIAGNOS Inc. Earnings Call